(Q36431610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

A G Zeimet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Uhl-Steidl

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E Müller-Holzner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Daxenbichler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C Marth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

O Dapunt

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

1646-1651

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bjc.1997.611

8 November 2019

exact match

0 references

cites work

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

Are CD44 variant isoforms involved in human tumour progression?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

De-novo expression of CD44 and survival in gastric cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

Prevention of tumor metastasis formation by anti-variant CD44.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228203

Soluble CD44 variants in serum of patients with prostate cancer and other urological malignancies

21 October 2018

1 reference

12 December 2020

Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer

1 reference

12 December 2020

Participation in normal immune responses of a metastasis-inducing splice variant of CD44

1 reference

12 December 2020

Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa

1 reference

12 December 2020

The prognostic value of nuclear roundness and neopterin in ovarian cancer

1 reference

12 December 2020

Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies

1 reference

12 December 2020

Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer

1 reference

12 December 2020

Serum CD44 in malignant lymphoma: an association with treatment response

1 reference

12 December 2020

Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins

1 reference

12 December 2020

Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cells

1 reference

12 December 2020

Effect of CD44v6 on survival in colorectal carcinoma

1 reference

12 December 2020

CD44 variant exon epitopes in primary breast cancer and length of survival

1 reference

12 December 2020

CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor

1 reference

12 December 2020

Prognostic value of CD44 splice variant expression in ovarian cancer

1 reference

12 December 2020

CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer

1 reference

12 December 2020

Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.611

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9413956%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference